MHRA - Medicines and Healthcare products Regulatory Agency
MHRA - Medicines and Healthcare products Regulatory Agency
04/15/2024 | Press release | Distributed by Public on 04/15/2024 11:40
MHRA performance data for assessment of clinical trials and established medicines
Transparency data
MHRA performance data for assessment of clinical trials and established medicines
MHRA performance metrics for clinical trials and established medicines assessment.
From:Medicines and Healthcare products Regulatory AgencyPublished14 April 2023Last updated 15 April 2024 - See all updates
Get emails about this page
Documents
Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (Clinical Trials: September 2023 - March 2024) (Clinical Investigations: April 2023 - March 2024)
PDF, 525 KB, 18 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - March 2024)
PDF, 305 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (February 2023 - February 2024)
PDF, 440 KB, 18 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - February 2024)
PDF, 304 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (February 2023 - January 2024)
PDF, 471 KB, 18 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - January 2024)
PDF, 302 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - December 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 301 KB, 5 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: December 2022 - December 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments
PDF, 624 KB, 18 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: December 2022 - November 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments
PDF, 473 KB, 17 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - November 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 1.2 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: November 2022 - October 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments
PDF, 472 KB, 17 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - October 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 1.22 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: October 2022 -September 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments
PDF, 495 KB, 23 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - September 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 1.18 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: September 2022 - August 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments
PDF, 518 KB, 14 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - August 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 1.22 MB, 24 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: August 2022 to September 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments
PDF, 531 KB, 15 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: August 2022 - July 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments
PDF, 408 KB, 15 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - July 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 973 KB, 23 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: July 2022 - June 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments
PDF, 403 KB, 14 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: June 2022 - May 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments
PDF, 402 KB, 14 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - June 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 503 KB, 22 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - May 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 521 KB, 20 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics January 2023 - April 2023: Assessment of New Marketing Authorisation Applications and Variations
PDF, 513 KB, 15 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Performance Metrics May 2022 - April 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments
PDF, 383 KB, 14 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Clinical Trials Performance Metrics: April 22 - March 23
PDF, 383 KB, 12 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
MHRA established medicines performance data - January to March 2023
PDF, 277 KB, 4 pages
This file may not be suitable for users of assistive technology.
Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.
Details
We publish routine updates to performance data for the assessment of clinical trials and established medicines within 15 days of the end of each month. This is to help improve the predictability of decision making in applications for clinical trials, marketing authorisations and variations to existing approvals.
Published 14 April 2023
Last updated 15 April 2024 + show all updates
Last updated 15 April 2024 + show all updates
-
15 April 2024
Published 'Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (Clinical Trials: September 2023 - March 2024) (Clinical Investigations: April 2023 - March 2024) & Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - March 2024)
-
15 March 2024
Published Clinical Trials Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (February 2023 - February 2024) & Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - February 2024).
-
15 February 2024
Published 'Performance Metrics: Assessment of New Marketing Authorisation Applications and Variations (January 2023 - January 2024)' & 'Clinical Trials Performance Metrics: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Amendments (February 2023 - January 2024)'
-
16 January 2024
Published 'Performance Metrics January 2023 - December 2023: Assessment of New Marketing Authorisation Applications and Variations' and 'Clinical Trials Performance Metrics: December 2022 - December 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments'
-
15 December 2023
Published 'Clinical Trials Performance Metrics: December 2022 - November 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments' and 'Performance Metrics January 2023 - November 2023: Assessment of New Marketing Authorisation Applications and Variations'.
-
15 November 2023
Published 'Clinical Trials Performance Metrics: November 2022 - October 2023: Assessment of Clinical Trial Authorisation Applications, Clinical Investigations and Substantial Amendments' & 'Performance Metrics January 2023 - October 2023: Assessment of New Marketing Authorisation Applications and Variations'
-
13 October 2023
Published 'Clinical Trials Performance Metrics: October 2022 -September 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments' and 'Performance Metrics January 2023 - September 2023: Assessment of New Marketing Authorisation Applications and Variations'.
-
15 September 2023
Published 'Clinical Trials Performance Metrics: September 2022 - August 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments' and 'Performance Metrics January 2023 - August 2023: Assessment of New Marketing Authorisation Applications and Variations'
-
7 September 2023
Published 'Clinical Trials Performance Metrics: August 2022 to September 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments'
-
15 August 2023
Published 'Clinical Trials Performance Metrics: July 2022 - July 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments' & 'Performance Metrics January 2023 - June 2023: Assessment of New Marketing Authorisation Applications and Variations'
-
14 July 2023
Added: Clinical Trials Performance Metrics: July 2022 - June 2023: Assessment of Clinical Trial Authorisation Applications and Substantial Amendments - file attachment & Performance Metrics January 2023 - June 2023: Assessment of New Marketing Authorisation Applications and Variations - file attachment
-
15 June 2023
Added 'Clinical Trials Performance Metrics: June 22 - May 23' and 'Performance Metrics January 23 - May 23: Assessment of New Marketing Authorisation Applications and Variations'
-
15 May 2023
Added latest performance metrics for 'Assessment of Clinical Trial Authorisation Applications and Substantial Amendments' and 'Assessment of New Marketing Authorisation Applications and Variations'
-
14 April 2023
First published.
Get emails about this page
Print this page